Duke University’s MURDOCK Study and Duke Clinical Research Institute (DCRI) will collaborate with Boehringer Ingelheim Pharmaceuticals on a new chronic obstructive pulmonary disease (COPD) study.

A Raleigh drugmaker hit its targets in a clinical trial for its lung disease treatment, putting the company on a potential path to obtaining approval from regulators. A local drugmaker has hit its ...

Grace Anne Dorney Koppel was told she only had a few years left after her 2001 COPD diagnosis. Now, the couple provides the treatment that keeps her 'very much alive 23 years later' Star Max via AP ...

While long-term smoking is one of the biggest risk factors for COPD, your environment also plays a massive role. If you have COPD, living somewhere with low pollution levels can help you manage your ...